Cuiling Qi Selected Research

Glipizide (Glucotrol)

1/2022	Glipizide Combined with ANP Suppresses Breast Cancer Growth and Metastasis by Inhibiting Angiogenesis through VEGF/VEGFR2 Signaling.
1/2016	Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis.
5/2015	Glipizide suppresses embryonic vasculogenesis and angiogenesis through targeting natriuretic peptide receptor A.
10/2014	Glipizide, an antidiabetic drug, suppresses tumor growth and metastasis by inhibiting angiogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cuiling Qi Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 04/2014
9	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2014
8	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2018
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2014
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2017
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2019
2	Fibrosis (Cirrhosis) 01/2021 - 12/2015
2	Inflammation (Inflammations) 01/2020 - 09/2015
2	Lung Neoplasms (Lung Cancer) 06/2015 - 07/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2015 - 04/2014
1	COVID-19 12/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Insulinoma 01/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2015
1	Atherosclerosis 09/2015
1	Lymphatic Metastasis 06/2015
1	Aneurysm (Aneurysms) 02/2015
1	Vascular System Injuries 02/2015
1	Carcinogenesis 01/2015
1	Carcinoma in Situ 07/2014

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2012
4	Glipizide (Glucotrol)FDA LinkGeneric 01/2022 - 10/2014
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2015
4	P-SelectinIBA 01/2017 - 01/2015
3	Pharmaceutical PreparationsIBA 01/2022 - 10/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2013
2	andrographolideIBA 01/2021 - 11/2013
2	2,3- dimethoxy- 5- methyl- 6- decyl- 1,4- benzoquinoneIBA 01/2021 - 01/2020
2	coenzyme Q10 (CoQ10)IBA 01/2021 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 10/2014
2	MicroRNAs (MicroRNA)IBA 01/2021 - 04/2014
2	CollagenIBA 01/2016 - 12/2015
1	LipidsIBA 01/2022
1	3-methylhistidineIBA 01/2022
1	formic acid (formate)IBA 01/2022
1	atrial natriuretic factor receptor AIBA 01/2022
1	Alanine (L-Alanine)FDA Link 01/2022
1	Aspartic Acid (Aspartate)FDA Link 01/2022
1	CreatineIBA 01/2022
1	Glutamine (L-Glutamine)FDA Link 01/2022
1	Inositol (Myoinositol)IBA 01/2022
1	Isoleucine (L-Isoleucine)FDA Link 01/2022
1	Leucine (L-Leucine)FDA Link 01/2022
1	Methionine (L-Methionine)FDA Link 01/2022
1	Atrial Natriuretic Factor (ANF)IBA 01/2022
1	Taurine FDA Link 01/2022
1	Valine (L-Valine)FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	Pyruvic Acid (Pyruvate)IBA 01/2022
1	Citric Acid (Citrate)FDA LinkGeneric 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2021
1	Small Cytoplasmic RNAIBA 12/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2021
1	Sirtuin 2IBA 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	Long Noncoding RNAIBA 01/2021
1	SirtuinsIBA 01/2021
1	MicellesIBA 01/2021
1	Immunomodulating AgentsIBA 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	Competitive Endogenous RNAIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 08/2020
1	CateninsIBA 08/2020
1	FilaminsIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	myricetinIBA 12/2019
1	Calcibiotic Root Canal SealerIBA 01/2019
1	LigandsIBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	HMGA ProteinsIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	AminopropionitrileIBA 01/2016
1	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2015
1	Phosphatidylinositols (Phosphatidylinositol)IBA 09/2015
1	CholesterolIBA 09/2015
1	Apolipoproteins E (ApoE)IBA 09/2015
1	mouse MIRN29 microRNAIBA 06/2015
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 06/2015
1	Sincalide FDA Link 06/2015
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 02/2015
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 02/2015
1	Matrix Metalloproteinases (MMPs)IBA 02/2015
1	Cell Adhesion MoleculesIBA 01/2015
1	glimepiride (Amarel)FDA LinkGeneric 10/2014
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2014
1	Bromodeoxyuridine (BrdU)IBA 07/2014
1	Messenger RNA (mRNA)IBA 07/2014
1	Small Interfering RNA (siRNA)IBA 07/2014
1	anthraceneIBA 07/2014
1	Collagen Type IV (Type IV Collagen)IBA 07/2014
1	Collagen Type I (Type I Collagen)IBA 07/2014

Therapy/Procedure

4	Therapeutics 01/2021 - 07/2014
1	Drug Therapy (Chemotherapy) 01/2021
1	Intraperitoneal Injections 09/2015
1	Ligation 02/2015